497 related articles for article (PubMed ID: 29948240)
1. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.
Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M
Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes and prognostic factors of patients with obstructive colorectal cancer: A multicenter retrospective cohort study.
Atsushi I; Mitsuyoshi O; Kazuya Y; Syuhei K; Noriyuki K; Masashi M; Akira W; Kentaro S; Nobuyuki K; Natsuko S; Jun W; Yasushi I; Chikara K; Itaru E
World J Gastroenterol; 2016 Jun; 22(22):5237-45. PubMed ID: 27298566
[TBL] [Abstract][Full Text] [Related]
4. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
5. Advanced Age Is a Risk Factor for Recurrence After Resection in Stage II Colorectal Cancer.
Mima K; Kurashige J; Miyanari N; Morito A; Yumoto S; Matsumoto T; Kosumi K; Inoue M; Mizumoto T; Kubota T; Baba H
In Vivo; 2020; 34(1):339-346. PubMed ID: 31882497
[TBL] [Abstract][Full Text] [Related]
6. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes of One Stage Surgery Using Transanal Colorectal Tube for Acute Colorectal Obstruction of Stage II/III Distal Colon Cancer.
Okuda Y; Yamada T; Hirata Y; Shimura T; Yamaguchi R; Sakamoto E; Sobue S; Nakazawa T; Kataoka H; Joh T
Cancer Res Treat; 2019 Apr; 51(2):474-482. PubMed ID: 29879759
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials.
Zhu L; Dong C; Cao Y; Fang X; Zhong C; Li D; Yuan Y
PLoS One; 2016; 11(5):e0154795. PubMed ID: 27138801
[TBL] [Abstract][Full Text] [Related]
11. A high preoperative carbohydrate antigen 19-9 level is a risk factor for recurrence in stage II colorectal cancer.
Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Murono K; Watanabe T
Acta Oncol; 2017 May; 56(5):634-638. PubMed ID: 27885879
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio may predict relapse free survival and overall survival in patients with stage II & III colorectal carcinoma.
Zekri J; Ahmad I; Fawzy E; Elkhodary TR; Al-Gahmi A; Hassouna A; El Sayed ME; Ur Rehman J; Karim SM; Bin Sadiq B
Hepatogastroenterology; 2015; 62(138):291-4. PubMed ID: 25916051
[TBL] [Abstract][Full Text] [Related]
14. The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer.
Xu G; Jiang L; Ye C; Qin G; Luo Z; Mo Y; Chen J
Front Immunol; 2021; 12():724429. PubMed ID: 34512652
[TBL] [Abstract][Full Text] [Related]
15. Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection.
Nozawa H; Sonoda H; Ishii H; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Shuno Y; Tanaka T; Kawai K; Hata K; Ishihara S
Int J Colorectal Dis; 2020 Jan; 35(1):177-180. PubMed ID: 31807855
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients: A Large Institutional-Based Retrospective Study.
Kim TJ; Kim ER; Hong SN; Chang DK; Kim YH
Medicine (Baltimore); 2016 May; 95(19):e3641. PubMed ID: 27175682
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
18. A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
Sho S; Court CM; Winograd P; Russell MM; Tomlinson JS
J Surg Oncol; 2017 Dec; 116(8):996-1004. PubMed ID: 28767131
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome after one-stage surgery without preoperative decompression for stage II/III malignant colorectal obstruction: a propensity score-matched analysis.
Takeyama H; Ikeda K; Danno K; Nishigaki T; Yamashita M; Taniguchi H; Oka Y
Int J Colorectal Dis; 2019 Nov; 34(11):1933-1943. PubMed ID: 31667590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
